Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise

cnbc.com/2025/07/17/novartis-novn-earnings-q1-20225-sales-of-kisqali-soar.html

Sales of breast cancer drug Kisqali grew 100% in the U.S. in the three months to June.

This story appeared on cnbc.com, 2025-07-17 13:10:05.
The Entire Business World on a Single Page. Free to Use →